BeStock  
Stocks › Biotechnology › AKTS

Aktis Oncology AKTS

US equityMarket cap rank #3226Biotechnology
$16.15 −$0.25 (-1.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.46 +1.92%
Open$16.32
Prev close$16.40
Day range$16.00 – $16.74
Volume375.0K
Market cap$901.14M
P/E (TTM)–
Dividend yield–

AKTS Stock News

Headlines matching Aktis Oncology or the AKTS ticker, most recent first.

  • Oppenheimer Initiates Aktis Oncology(AKTS.US) With Buy Rating, Announces Target Price $40Market news · 9 Sep 2026 · Direct mention
  • Wedbush Initiates Aktis Oncology(AKTS.US) With Buy Rating, Announces Target Price $35Market news · 19 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $33Market news · 14 Aug 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These NA Companies: Aktis Oncology, Inc. (AKTS), Bullish (BLSH) and SanDisk Corp (SNDK) PositiveTipRanks · 14 Aug 2026 · Direct mention
  • William Blair Maintains Aktis Oncology(AKTS.US) With Buy RatingMarket news · 14 Aug 2026 · Direct mention
  • Aktis Oncology, Inc. (AKTS) Receives a Buy From Bank of America SecuritiesTipRanks · 14 Aug 2026 · Direct mention
  • Analysts Are Bullish on Top NA Stocks: Aktis Oncology, Inc. (AKTS), Yesway Inc Class A (YSWY) PositiveTipRanks · 14 Aug 2026 · Direct mention
  • BofA Securities Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $34Market news · 14 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Aktis Oncology(AKTS.US) With Buy Rating, Raises Target Price to $33 PositiveMarket news · 14 Jul 2026 · Direct mention
  • J.P. Morgan Keeps Their Buy Rating on Aktis Oncology, Inc. (AKTS)TipRanks · 14 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $35Market news · 3 Jun 2026 · Direct mention
  • H.C. Wainwright Maintains Aktis Oncology(AKTS.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 3 Jun 2026 · Direct mention
  • Raymond James Maintains Aktis Oncology(AKTS.US) With Buy Rating, Maintains Target Price $40Market news · 16 Jun 2026 · Direct mention
  • Bank of America Securities Remains a Buy on Aktis Oncology, Inc. (AKTS)TipRanks · 1 Jun 2026 · Direct mention
  • William Blair Initiates Aktis Oncology(AKTS.US) With Buy RatingMarket news · 6 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AKTS.

Sign in to join the discussion.

Scroll to Top